Latin America is undergoing dramatic demographic and epidemiological changes. Its population is rapidly aging, and there is a worrisome increase in the prevalen...
José Javier Handal, Chief Medical Officer at MRx Solution
Javier Handal is a Medical Doctor with expertise in clinical research and pharmaceutical industry operations. As the leader of MRx Solution, a Site Management Organization (SMO), he is driving the development of a robust network of research sites across Central America. Javier excels in building strategic partnerships, optimizing operations, and ensuring adherence to international research standards. His proactive mindset, attention to detail, and commitment to excellence enable him to deliver impactful outcomes. Dedicated to advancing healthcare innovation in the region, he leverages leadership, expertise, and collaboration to make significant contributions to clinical research.
--------
27:49
Andrew Ortega-Verdaguer, IntelVasc Inc.
Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large teams at top pharmaceutical and medical device companies, including Novartis, Terumo, and Penumbra Inc. Andrew is a proud graduate of the IGNITE Program at Stanford Graduate School of Business and has also studied at several other prestigious international business schools. His expertise and journey in medical innovation make him a key voice in understanding the challenges and opportunities within the industry.
--------
31:28
Daniel Estay, Founder & CEO at SonoVascular
In this episode of LATAM Medtech Leaders, we sit down with Daniel Estay, a seasoned medical technology executive with a wealth of global experience. Daniel shares insights from his journey leading and developing fully integrated businesses across small, mid-sized, and large companies. With extensive expertise in general management, commercial operations, and business development, he offers a unique perspective on navigating the complexities of the medtech industry. We delve into his deep understanding of U.S. and international markets, including the opportunities and challenges of emerging markets in Asia Pacific and Latin America. Whether you're a medtech entrepreneur, investor, or enthusiast, this episode is packed with valuable lessons and strategies for driving success in the ever-evolving healthcare landscape. Tune in to explore the future of medtech through Daniel's expert lens!
--------
23:32
Paulo Fernandes, C2O Fundador & Principal
Paulo Fernandes is a distinguished clinical research executive with extensive experience in international clinical trials across various phases and therapeutic areas. With a solid foundation in the CRO industry, he has successfully held roles in project management, start-up, operations management, and business development. Paulo has worked at renowned CROs such as PPD, Covance, and IQVIA. Recently, he structured a healthcare sector start-up for a group of investors, showcasing his entrepreneurial spirit and commitment to high-impact public health initiatives. Additionally, he has 10 years of experience at the Brazilian Association of Clinical Research Organizations, including 4 years as the President of the Board of Directors. Paulo holds a specialization in Clinical Pharmacology from USCS, a degree in Pharmacy and Biochemistry from FCF-USP, and training in Business and Project Management from FIA, along with an Executive MBA from INSPER.
--------
25:35
Miriam Serrano, Clinical Research Expert
Miriam is a seasoned professional in Health and Law, specializing in Sanitary Regulation and Clinical Research. With over 20 years of experience, she has a track record in planning and executing global, regional, and local clinical development programs, including Bioequivalence studies and Phase I-IV clinical trials. Her expertise spans Clinical Monitoring, Quality Assurance, Budgeting, Contracts & Payments Control, Clinical Trial Supplies, Master File, Pharmacovigilance, and Regulatory Affairs within both pharmaceutical industries and CROs, at national and international levels. She is recognized in the sector as a key opinion leader and a local expert in regulatory matters. Her leadership and active participation in gremial improvement initiatives have been pivotal, building synergies with authorities, academic, and industrial colleagues to further the development and progress of Clinical Research.
Latin America is undergoing dramatic demographic and epidemiological changes. Its population is rapidly aging, and there is a worrisome increase in the prevalence of chronic diseases. Despite this, innovative medical technologies sometimes take years to reach these patients. US and European Medical technology ("Medtech") companies struggle to find a cost-effective first-in-human clinical research center or to gain market share in Latin America; this prevents patients in Latin America from having faster and easier access to innovative and breakthrough medical technologies.We realized that a) the majority of US and European small and mid-size Medtech companies fail in their attempt to enter Latin America; b) that these companies have no source of quality, reliable, and actionable information on how to reach the right patients in the region, c) that these companies have a hard time finding an expert to guide them to succeed in the region. As a consequence, patients in Latin America have delayed access to breakthrough and innovative medical technologies. We decided to create this podcast to fix these problems by becoming part of the solution to accelerate the penetration of breakthrough medical innovations in Latin America.
![Podcast Resetea tus límites con Rebeca Muñoz](https://co.radio.net/podcast-images/175/resetea-tus-limites2.jpeg?version="c573bb2f4e90d6b63b73c07d9da8efa6-1")
![Podcast Seminario Fenix | Brian Tracy](https://co.radio.net/podcast-images/300/seminario-fenix-brian-tracy4.jpeg?version="52f3201fca327db69cf8ddc3dbb3861b")
Colombia